EDIT Latest Headlines

Analysts Offer Insights on Healthcare Companies: Zura Bio (ZURA), Adaptive Biotechnologies (ADPT) and Editas Medicine (EDIT)

at www.tipranks.com (Tue, 10-Nov 7:20 AM)

RBC Capital Reaffirms Their Hold Rating on Editas Medicine (EDIT)

at www.tipranks.com (Tue, 10-Nov 6:56 AM)

Analysts Have Conflicting Sentiments on These Healthcare Companies: Viridian Therapeutics (VRDN), Editas Medicine (EDIT) and Praxis Precision Medicines (PRAX)

at www.tipranks.com (Tue, 10-Nov 5:50 AM)

Editas Medicine GAAP EPS of -$0.15 beats by $0.04, revenue of $10.37M beats by $5.84M

at seekingalpha.com (Mon, 9-Nov 7:03 AM)